FULC · Company research
Fulcrum Therapeutics, Inc. Common Stock (FULC): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 3.67 | $283,702,080 | 235236080.00 | 8.3777777777777778 | — | — | — | 0.91311496409685320425 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.